[Effects of hepatoprotective agents containing phospholipids on cytochrome P-450-dependent antitoxic liver function during experimental toxic hepatitis].
Saratikov
A S
AS
Vengerovskiĭ
A I
AI
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002252:Carbon Tetrachloride Poisoning / Q000378:metabolism; D002338:Carotenoids / Q000494:pharmacology; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004338:Drug Combinations; D008658:Inactivation, Metabolic; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D010713:Phosphatidylcholines / Q000494:pharmacology; D010743:Phospholipids / Q000494:pharmacology*; D020005:Propanols; D051381:Rats; D012838:Silymarin / Q000494:pharmacology
D000975:Antioxidants; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010743:Phospholipids; D020005:Propanols; D012838:Silymarin; C064845:eplir; C011246:essential 303 forte; D002338:Carotenoids; C006463:allyl alcohol; D003577:Cytochrome P-450 Enzyme System
Vliianie gepatoprotektorov, soderzhashchikh fosfolipidy, na zavisimuiu ot tsitokhroma P-450 antitoksicheskuiu funktsiiu pecheni pri éksperimental'nom toksicheskom gepatite.